FDA Clears First Drug for Rare Genetic Causes of Severe Obesity ...Middle East

Setmelanotide (Imcivree) is indicated for weight management in adults and children as young as 6 years with severe obesity driven by genetic deficits in the melanocortin-4 receptor pathway. FDA Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Clears First Drug for Rare Genetic Causes of Severe Obesity )

Also on site :

• Possible tornado in Phelps on Monday
• Evacuations ordered after brush fire breaks out in Laguna Beach
• Photos: A blaze at Cairo telecommunications building causes service disruptions